相关实验视频

Updated: May 5, 2026

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: December 22, 2020

呼吁提高透明度,改善报告和解释使用心脏电生理学替代终点的试验

Larisa G Tereshchenko¹, Anthony Muchai Manyara², Oriana Ciani³

¹Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

|February 28, 2025

概括

新的检查清单提高了使用代用终点的随机对照试验 (RCT) 的透明度. "SPIRIT-Surrogate"和"CONSORT-Surrogate"指南增强了对心脏电生理学研究的报告.

科学领域:

临床试验方法论临床试验方法论
心血管研究研究心血管研究
生物统计学生物统计学

背景情况:

替代终点经常用于心脏电生理学 (EP) 随机对照试验 (RCT).
替代终点的定义和应用需要仔细考虑,以避免潜在的悖论.
关于试验方案和结果的透明报告对于科学完整性至关重要.

研究的目的:

介绍和解释最近的CONSORT替代品和SPIRIT替代品检查清单.
讨论心脏EPRCT中代用终点的定义和含义.
强调在临床试验中透明报告的重要性.

主要方法:

审查SPIRIT-Surrogate和CONSORT-Surrogate检查清单,作为现有报告准则的扩展.
讨论代孕与目标/最终终点的讨论,用心脏EP的具体例子.
分析历史替代悖论及其理论框架.

主要成果:

替代体的SPIRIT和替代体的CONSORT为使用替代终点的RCT提供了基本的指导方针.
心律不整通常是EP研究中的替代终点,需要仔细的证明.
了解代孕悖论是准确解释试验结果的关键.

结论:

心脏电生理学的临床研究人员必须采用SPIRIT-Surrogate和CONSORT-Surrogate的检查清单.
实施这些指导方针确保了RCT协议和结果的透明报告.
提高透明度可以减轻与替代终点利用相关的风险.

关键词:

生物标志物生物标志物检查清单检查清单检查清单临床试验临床试验是指临床试验的临床试验.结果结果的结果.随机对照试验是随机对照试验.研究设计研究设计研究设计标准标准标准标准替代终点替代终点替代终点替代品标记器是替代品标记器.

更多相关视频

In Silico Clinical Trials for Cardiovascular Disease

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation

A Cardiac Microphysiological System for Studying Ca²⁺ Propagation via Non-genetic Optical Stimulation

Published on: March 21, 2025

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...